On the 19th, Celltrion Pharm announced its 'Vision 2030,’ which outlines the company’s vision to become one of the top five pharmaceutical companies in Korea by 2030.

Until recently, Celltrion Pharm was promoting a merger with Celltrion, but the plan was reviewed again due to shareholder opposition, upon which the final decision was made not to merge on the 16th. Vision 2030 is the first mid- to long-term established for Celltrion Pharm since the cancellation of the merger.

In Vision 2030, Celltrion Pharm presented detailed projects for each of the following sectors: ▲manufacturing, ▲R&D, and ▲sales as a comprehensive pharmaceutical company that manufactures and sells chemical and b